These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 21072224)

  • 21. Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages.
    Burton MJ; Holland MJ; Faal N; Aryee EA; Alexander ND; Bah M; Faal H; West SK; Foster A; Johnson GJ; Mabey DC; Bailey RL
    Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4215-22. PubMed ID: 14507864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What is causing active trachoma? The role of nonchlamydial bacterial pathogens in a low prevalence setting.
    Burton MJ; Hu VH; Massae P; Burr SE; Chevallier C; Afwamba IA; Courtright P; Weiss HA; Mabey DC; Bailey RL
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):6012-7. PubMed ID: 21693601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of Infection with Chlamydia trachomatis from Migrants to Communities Undergoing Mass Drug Administration for Trachoma Control.
    West SK; Munoz BE; Mkocha H; Gaydos C; Quinn T
    Ophthalmic Epidemiol; 2015; 22(3):170-5. PubMed ID: 26158574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trachoma and ocular Chlamydia trachomatis rates in children in trachoma-endemic communities enrolled for at least three years in the Tanzania National Trachoma Control Programme.
    Mkocha H; Munoz B; West S
    Tanzan J Health Res; 2009 Jul; 11(3):103-10. PubMed ID: 20734706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of flies and provision of latrines in trachoma control: cluster-randomised controlled trial.
    Emerson PM; Lindsay SW; Alexander N; Bah M; Dibba SM; Faal HB; Lowe KO; McAdam KP; Ratcliffe AA; Walraven GE; Bailey RL
    Lancet; 2004 Apr; 363(9415):1093-8. PubMed ID: 15064026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trachoma risk factors in Oromia Region, Ethiopia.
    Shafi Abdurahman O; Last A; Macleod D; Habtamu E; Versteeg B; Dumessa G; Guye M; Nure R; Adugna D; Miecha H; Greenland K; Burton MJ
    PLoS Negl Trop Dis; 2023 Nov; 17(11):e0011679. PubMed ID: 37934731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting antibiotics to households for trachoma control.
    Blake IM; Burton MJ; Solomon AW; West SK; Basáñez MG; Gambhir M; Bailey RL; Mabey DC; Grassly NC
    PLoS Negl Trop Dis; 2010 Nov; 4(11):e862. PubMed ID: 21072225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District Survey.
    West SK; Munoz B; Weaver J; Mrango Z; Dize L; Gaydos C; Quinn TC; Martin DL
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004352. PubMed ID: 26771906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conjunctival transcriptome profiling of Solomon Islanders with active trachoma in the absence of Chlamydia trachomatis infection.
    Vasileva H; Butcher R; Pickering H; Sokana O; Jack K; Solomon AW; Holland MJ; Roberts CH
    Parasit Vectors; 2018 Feb; 11(1):104. PubMed ID: 29467021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and risk factors for trachoma and ocular Chlamydia trachomatis infection in Niger.
    Abdou A; Nassirou B; Kadri B; Moussa F; Munoz BE; Opong E; West SK
    Br J Ophthalmol; 2007 Jan; 91(1):13-7. PubMed ID: 16899525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for ocular infection with Chlamydia trachomatis in children 6 months following mass treatment in Tanzania.
    Cajas-Monson LC; Mkocha H; Muñoz B; Quinn TC; Gaydos CA; West SK
    PLoS Negl Trop Dis; 2011 Mar; 5(3):e978. PubMed ID: 21423645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low Prevalence of Ocular Chlamydia trachomatis Infection and Active Trachoma in the Western Division of Fiji.
    Macleod CK; Butcher R; Mudaliar U; Natutusau K; Pavluck AL; Willis R; Alexander N; Mabey DC; Cikamatana L; Kama M; Rafai E; Roberts CH; Solomon AW
    PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004798. PubMed ID: 27404379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Constant ocular infection with Chlamydia trachomatis predicts risk of scarring in children in Tanzania.
    Wolle MA; Muñoz BE; Mkocha H; West SK
    Ophthalmology; 2009 Feb; 116(2):243-7. PubMed ID: 19091415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation (ASANTE) Trial: Design and Baseline Characteristics.
    Ervin AM; Mkocha H; Munoz B; Dreger K; Dize L; Gaydos C; Quinn TC; West SK
    Ophthalmic Epidemiol; 2016 Dec; 23(6):347-353. PubMed ID: 27820670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OmpA genotypic evidence for persistent ocular Chlamydia trachomatis infection in Tanzanian village women.
    Smith A; Muñoz B; Hsieh YH; Bobo L; Mkocha H; West S
    Ophthalmic Epidemiol; 2001 Jul; 8(2-3):127-35. PubMed ID: 11471082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measuring Trachomatous Inflammation-Intense (TI) When Prevalence Is Low Provides Data on Infection With Chlamydia trachomatis.
    Zambrano AI; Muñoz BE; Mkocha H; Dize L; Gaydos CA; Quinn T; West SK
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):997-1000. PubMed ID: 28535271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of Chlamydia trachomatis ocular infection in trachoma-endemic communities by rRNA amplification.
    Yang JL; Hong KC; Schachter J; Moncada J; Lekew T; House JI; Zhou Z; Neuwelt MD; Rutar T; Halfpenny C; Shah N; Whitcher JP; Lietman TM
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):90-4. PubMed ID: 18689701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for active trachoma and Chlamydia trachomatis infection in rural Ethiopia after mass treatment with azithromycin.
    Edwards T; Harding-Esch EM; Hailu G; Andreason A; Mabey DC; Todd J; Cumberland P
    Trop Med Int Health; 2008 Apr; 13(4):556-65. PubMed ID: 18282237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The development of an age-structured model for trachoma transmission dynamics, pathogenesis and control.
    Gambhir M; Basáñez MG; Burton MJ; Solomon AW; Bailey RL; Holland MJ; Blake IM; Donnelly CA; Jabr I; Mabey DC; Grassly NC
    PLoS Negl Trop Dis; 2009 Jun; 3(6):e462. PubMed ID: 19529762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units.
    Burr SE; Hart J; Samikwa L; Chaima D; Cooley G; Martin D; Masika M; Solomon AW; Bailey RL; Kalua K
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007749. PubMed ID: 31658258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.